Press ReleasesRead more
Integrated CTx Manufacturing
As a unique differentiator within the specific field of cellular therapies, OncoBay can support adoptive cell therapy manufacturing through our partnership with Moffitt's cGMP manufacturing facility. Together, we can support from translational to IND through clinical trial manufacturing and full-service operations.
The OncoBay offering provides true vein-to-vein control throughout the cell manufacturing process with transparency through each step of the supply chain. Our partners are never out of touch.
Learn more about the Moffitt CTx capability here.